|
Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 167 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Microbiology Culture market i.....
Introduction GlobalData’s new report, “Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Microbiology Culture market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within seven market categories – Bacterial Identification & Susceptibility Testing, Blood Culture ,Mycobacteria Culture, Microbiology Analyzers, Immunological Culture Identification, Parasitology Culture and Mycology Culture. The report also provides company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. Scope - Market size data for Microbiology Culture market categories – Bacterial Identification & Susceptibility Testing, Blood Culture ,Mycobacteria Culture, Microbiology Analyzers, Immunological Culture Identification, Parasitology Culture and Mycology Culture. - Annualized market revenues ($m) data for each of the segments and sub-segments within the seven market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. - 2010 company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries. - Global corporate-level profiles of key companies operating within the Microbiology Culture market in BRICS. - Key players covered include bioMerieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Alere Inc., Siemens Healthcare and J.Mitra & Co. Pvt Ltd. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Microbiology Culture competitive landscape in BRICS. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights bioMerieux S.A. Becton, Dickinson and Company Bio-Rad Laboratories, Inc. Thermo Fisher Scientific Inc. Alere Inc. Siemens Healthcare J.Mitra & Co. Pvt Ltd HIMEDIA LABORATORIES. PVT. LTD. Tulip Group Span Diagnostics Ltd. Trivitron Healthcare Pvt Ltd. [Studien Infos ausblenden] |
|||||||||||
|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 10 2 Introduction 13 2.1 What is This Report About? 13 3 Microbiology Culture in BRICS 14 3.1 Microbiology Culture, BRICS, Overall Revenue ($m), 2003-2017 14 3.2 Microbiology Culture, BRICS, Company share (2009-2010) 20 4 Microbiology Culture In Brazil 22 4.1 Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 22 4.2 Bacterial Identification & Susceptibility Testing In Brazil 28 4.2.1 Bacterial Identification & Susceptibility Testing, Brazil, Overall Revenue (2003-2017) 28 4.3 Blood Culture In Brazil 30 4.3.1 Blood Culture, Brazil, Overall Revenue (2003-2017) 30 4.4 Microbiology Analyzers In Brazil 32 4.4.1 Microbiology Analyzers, Brazil, Overall Revenue (2003-2017) 32 4.5 Mycobacteria Culture In Brazil 36 4.5.1 Mycobacteria Culture, Brazil, Overall Revenue (2003-2017) 36 4.6 Mycology Culture In Brazil 38 4.6.1 Mycology Culture, Brazil, Overall Revenue (2003-2017) 38 4.7 Immunological Culture Identification In Brazil 40 4.7.1 Immunological Culture Identification, Brazil, Overall Revenue (2003-2017) 40 4.8 Parasitology Culture In Brazil 42 4.8.1 Parasitology Culture, Brazil, Overall Revenue (2003-2017) 42 4.9 Microbiology Culture, Brazil, Distribution Share (2009-2010) 44 4.10 Microbiology Culture, Brazil, Company share (2009-2010) 45 5 Microbiology Culture In Russian Federation 46 5.1 Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 46 5.2 Bacterial Identification & Susceptibility Testing In Russian Federation 52 5.2.1 Bacterial Identification & Susceptibility Testing, Russian Federation, Overall Revenue (2003-2017) 52 5.3 Blood Culture In Russian Federation 54 5.3.1 Blood Culture, Russian Federation, Overall Revenue (2003-2017) 54 5.4 Microbiology Analyzers In Russian Federation 56 5.4.1 Microbiology Analyzers, Russian Federation, Overall Revenue (2003-2017) 56 5.5 Immunological Culture Identification In Russian Federation 60 5.5.1 Immunological Culture Identification, Russian Federation, Overall Revenue (2003-2017) 60 5.6 Mycobacteria Culture In Russian Federation 63 5.6.1 Mycobacteria Culture, Russian Federation, Overall Revenue (2003-2017) 63 5.7 Mycology Culture In Russian Federation 65 5.7.1 Mycology Culture, Russian Federation, Overall Revenue (2003-2017) 65 5.8 Parasitology Culture In Russian Federation 67 5.8.1 Parasitology Culture, Russian Federation, Overall Revenue (2003-2017) 67 5.9 Microbiology Culture, Russian Federation, Distribution Share (2009-2010) 69 5.10 Microbiology Culture, Russian Federation, Company share (2009-2010) 70 6 Microbiology Culture In India 72 6.1 Microbiology Culture, India, Overall Revenue ($m), USD Actual, 2003-2017 72 6.2 Blood Culture In India 78 6.2.1 Blood Culture, India, Overall Revenue (2003-2017) 78 6.3 Mycobacteria Culture In India 80 6.3.1 Mycobacteria Culture, India, Overall Revenue (2003-2017) 80 6.4 Bacterial Identification & Susceptibility Testing In India 82 6.4.1 Bacterial Identification & Susceptibility Testing, India, Overall Revenue (2003-2017) 82 6.5 Immunological Culture Identification In India 84 6.5.1 Immunological Culture Identification, India, Overall Revenue (2003-2017) 84 6.6 Parasitology Culture In India 86 6.6.1 Parasitology Culture, India, Overall Revenue (2003-2017) 86 6.7 Microbiology Analyzers In India 88 6.7.1 Microbiology Analyzers, India, Overall Revenue (2003-2017) 88 6.8 Mycology Culture In India 92 6.8.1 Mycology Culture, India, Overall Revenue (2003-2017) 92 6.9 Microbiology Culture, India, Distribution Share (2009-2010) 94 6.10 Microbiology Culture, India, Company Share (2009-2010) 95 7 Microbiology Culture In China 97 7.1 Microbiology Culture, China, Overall Revenue ($m), USD Actual, 2003-2017 97 7.2 Blood Culture In China 103 7.2.1 Blood Culture, China, Overall Revenue (2003-2017) 103 7.3 Microbiology Analyzers In China 105 7.3.1 Microbiology Analyzers, China, Overall Revenue (2003-2017) 105 7.4 Mycobacteria Culture In China 109 7.4.1 Mycobacteria Culture, China, Overall Revenue (2003-2017) 109 7.5 Bacterial Identification & Susceptibility Testing In China 111 7.5.1 Bacterial Identification & Susceptibility Testing, China, Overall Revenue (2003-2017) 111 7.6 Immunological Culture Identification In China 113 7.6.1 Immunological Culture Identification, China, Overall Revenue (2003-2017) 113 7.7 Parasitology Culture In China 115 7.7.1 Parasitology Culture, China, Overall Revenue (2003-2017) 115 7.8 Mycology Culture In China 117 7.8.1 Mycology Culture, China, Overall Revenue (2003-2017) 117 7.9 Microbiology Culture, China, Distribution Share (2009-2010) 119 7.10 Microbiology Culture, China, Company share (2009-2010) 120 8 Microbiology Culture In South Africa 122 8.1 Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 122 8.2 Microbiology Analyzers In South Africa 128 8.2.1 Microbiology Analyzers, South Africa, Overall Revenue (2003-2017) 128 8.3 Mycobacteria Culture In South Africa 132 8.3.1 Mycobacteria Culture, South Africa, Overall Revenue (2003-2017) 132 8.4 Blood Culture In South Africa 134 8.4.1 Blood Culture, South Africa, Overall Revenue (2003-2017) 134 8.5 Bacterial Identification & Susceptibility Testing In South Africa 136 8.5.1 Bacterial Identification & Susceptibility Testing, South Africa, Overall Revenue (2003-2017) 136 8.6 Immunological Culture Identification In South Africa 138 8.6.1 Immunological Culture Identification, South Africa, Overall Revenue (2003-2017) 138 8.7 Parasitology Culture In South Africa 140 8.7.1 Parasitology Culture, South Africa, Overall Revenue (2003-2017) 140 8.8 Mycology Culture In South Africa 142 8.8.1 Mycology Culture, South Africa, Overall Revenue (2003-2017) 142 8.9 Microbiology Culture, South Africa, Distribution Share (2009-2010) 144 8.10 Microbiology Culture, South Africa, Company share (2009-2010) 145 9 Overview of Key Companies in BRICS Microbiology Culture Market 147 9.1 bioMerieux S.A. 147 9.1.1 Company Overview 147 9.1.2 Share in the BRICS Microbiology Culture Market 148 9.2 Becton, Dickinson and Company 149 9.2.1 Company Overview 149 9.2.2 Share in the BRICS Microbiology Culture Market 150 9.3 Bio-Rad Laboratories, Inc. 151 9.3.1 Company Overview 151 9.3.2 Share in the BRICS Microbiology Culture Market 152 9.4 Thermo Fisher Scientific Inc. 153 9.4.1 Company Overview 153 9.4.2 Share in the BRICS Microbiology Culture Market 154 9.5 Alere Inc. 155 9.5.1 Company Overview 155 9.5.2 Share in the BRICS Microbiology Culture Market 156 9.6 Siemens Healthcare 157 9.6.1 Company Overview 157 9.6.2 Share in the BRICS Microbiology Culture Market 158 9.7 J.Mitra & Co. Pvt Ltd 159 9.7.1 Company Overview 159 9.8 HIMEDIA LABORATORIES. PVT. LTD. 160 9.8.1 Company Overview 160 9.9 Tulip Group 160 9.9.1 Company Overview 160 9.10 Span Diagnostics Ltd. 160 9.10.1 Company Overview 160 9.11 Trivitron Healthcare Pvt Ltd. 161 9.11.1 Company Overview 161 10 Appendix 162 10.1 Definitions of Markets Covered in the Report 163 10.1.1 Microbiology Culture 163 10.2 Research Methodology 164 10.3 Secondary Research 164 10.4 Primary Research 165 10.5 Models 165 10.6 Forecasts 166 10.7 Expert Panels 166 10.8 GlobalData Consulting 166 10.9 Currency Conversion 167 10.10 Contact Us 167 10.11 Disclaimer 167 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
1.1 List of Tables Table 1: Microbiology Culture, BRICS, Overall Revenue ($m), 2003-2017 15 Table 2: Microbiology Culture, BRICS, Overall Revenue ($m), Historic, 2003-2010 17 Table 3: Microbiology Culture, BRICS, Overall Revenue ($m), Forecast, 2010-2017 19 Table 4: Microbiology Culture, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 21 Table 5: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23 Table 6: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25 Table 7: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27 Table 8: Bacterial Identification & Susceptibility Testing, Brazil, Revenue ($m), Historic, 2003-2010 28 Table 9: Bacterial Identification & Susceptibility Testing, Brazil, Revenue ($m), Forecast, 2010-2017 29 Table 10: Blood Culture, Brazil, Revenue ($m), Historic, 2003-2010 30 Table 11: Blood Culture, Brazil, Revenue ($m), Forecast, 2010-2017 31 Table 12: Microbiology Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 33 Table 13: Microbiology Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 35 Table 14: Mycobacteria Culture, Brazil, Revenue ($m), Historic, 2003-2010 36 Table 15: Mycobacteria Culture, Brazil, Revenue ($m), Forecast, 2010-2017 37 Table 16: Mycology Culture, Brazil, Revenue ($m), Historic, 2003-2010 38 Table 17: Mycology Culture, Brazil, Revenue ($m), Forecast, 2010-2017 39 Table 18: Immunological Culture Identification, Brazil, Revenue ($m), Historic, 2003-2010 40 Table 19: Immunological Culture Identification, Brazil, Revenue ($m), Forecast, 2010-2017 41 Table 20: Parasitology Culture, Brazil, Revenue ($m), Historic, 2003-2010 42 Table 21: Parasitology Culture, Brazil, Revenue ($m), Forecast, 2010-2017 43 Table 22: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44 Table 23: Microbiology Culture, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 45 Table 24: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 47 Table 25: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 49 Table 26: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 51 Table 27: Bacterial Identification & Susceptibility Testing, Russian Federation, Revenue ($m), Historic, 2003-2010 52 Table 28: Bacterial Identification & Susceptibility Testing, Russian Federation, Revenue ($m), Forecast, 2010-2017 53 Table 29: Blood Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 54 Table 30: Blood Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 55 Table 31: Microbiology Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 57 Table 32: Microbiology Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 59 Table 33: Immunological Culture Identification, Russian Federation, Revenue ($m), Historic, 2003-2010 61 Table 34: Immunological Culture Identification, Russian Federation, Revenue ($m), Forecast, 2010-2017 62 Table 35: Mycobacteria Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 63 Table 36: Mycobacteria Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 64 Table 37: Mycology Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 65 Table 38: Mycology Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 66 Table 39: Parasitology Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 67 Table 40: Parasitology Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 68 Table 41: Microbiology Culture, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 69 Table 42: Microbiology Culture, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 71 Table 43: Microbiology Culture, India, Overall Revenue ($m), USD Actual, 2003-2017 73 Table 44: Microbiology Culture, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 75 Table 45: Microbiology Culture, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 77 Table 46: Blood Culture, India, Revenue ($m), Historic, 2003-2010 78 Table 47: Blood Culture, India, Revenue ($m), Forecast, 2010-2017 79 Table 48: Mycobacteria Culture, India, Revenue ($m), Historic, 2003-2010 80 Table 49: Mycobacteria Culture, India, Revenue ($m), Forecast, 2010-2017 81 Table 50: Bacterial Identification & Susceptibility Testing, India, Revenue ($m), Historic, 2003-2010 82 Table 51: Bacterial Identification & Susceptibility Testing, India, Revenue ($m), Forecast, 2010-2017 83 Table 52: Immunological Culture Identification, India, Revenue ($m), Historic, 2003-2010 84 Table 53: Immunological Culture Identification, India, Revenue ($m), Forecast, 2010-2017 85 Table 54: Parasitology Culture, India, Revenue ($m), Historic, 2003-2010 86 Table 55: Parasitology Culture, India, Revenue ($m), Forecast, 2010-2017 87 Table 56: Microbiology Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 89 Table 57: Microbiology Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 91 Table 58: Mycology Culture, India, Revenue ($m), Historic, 2003-2010 92 Table 59: Mycology Culture, India, Revenue ($m), Forecast, 2010-2017 93 Table 60: Microbiology Culture, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 94 Table 61: Microbiology Culture, India, Company Share by Revenue ($m), USD Actual 2009-2010 96 Table 62: Microbiology Culture, China, Overall Revenue ($m), USD Actual, 2003-2017 98 Table 63: Microbiology Culture, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 100 Table 64: Microbiology Culture, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 102 Table 65: Blood Culture, China, Revenue ($m), Historic, 2003-2010 103 Table 66: Blood Culture, China, Revenue ($m), Forecast, 2010-2017 104 Table 67: Microbiology Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 106 Table 68: Microbiology Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 108 Table 69: Mycobacteria Culture, China, Revenue ($m), Historic, 2003-2010 109 Table 70: Mycobacteria Culture, China, Revenue ($m), Forecast, 2010-2017 110 Table 71: Bacterial Identification & Susceptibility Testing, China, Revenue ($m), Historic, 2003-2010 111 Table 72: Bacterial Identification & Susceptibility Testing, China, Revenue ($m), Forecast, 2010-2017 112 Table 73: Immunological Culture Identification, China, Revenue ($m), Historic, 2003-2010 113 Table 74: Immunological Culture Identification, China, Revenue ($m), Forecast, 2010-2017 114 Table 75: Parasitology Culture, China, Revenue ($m), Historic, 2003-2010 115 Table 76: Parasitology Culture, China, Revenue ($m), Forecast, 2010-2017 116 Table 77: Mycology Culture, China, Revenue ($m), Historic, 2003-2010 117 Table 78: Mycology Culture, China, Revenue ($m), Forecast, 2010-2017 118 Table 79: Microbiology Culture, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 119 Table 80: Microbiology Culture, China, Company share by Revenue ($m), USD Actual 2009-2010 121 Table 81: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 123 Table 82: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 125 Table 83: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 127 Table 84: Microbiology Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 129 Table 85: Microbiology Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 131 Table 86: Mycobacteria Culture, South Africa, Revenue ($m), Historic, 2003-2010 132 Table 87: Mycobacteria Culture, South Africa, Revenue ($m), Forecast, 2010-2017 133 Table 88: Blood Culture, South Africa, Revenue ($m), Historic, 2003-2010 134 Table 89: Blood Culture, South Africa, Revenue ($m), Forecast, 2010-2017 135 Table 90: Bacterial Identification & Susceptibility Testing, South Africa, Revenue ($m), Historic, 2003-2010 136 Table 91: Bacterial Identification & Susceptibility Testing, South Africa, Revenue ($m), Forecast, 2010-2017 137 Table 92: Immunological Culture Identification, South Africa, Revenue ($m), Historic, 2003-2010 138 Table 93: Immunological Culture Identification, South Africa, Revenue ($m), Forecast, 2010-2017 139 Table 94: Parasitology Culture, South Africa, Revenue ($m), Historic, 2003-2010 140 Table 95: Parasitology Culture, South Africa, Revenue ($m), Forecast, 2010-2017 141 Table 96: Mycology Culture, South Africa, Revenue ($m), Historic, 2003-2010 142 Table 97: Mycology Culture, South Africa, Revenue ($m), Forecast, 2010-2017 143 Table 98: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 144 Table 99: Microbiology Culture, South Africa, Company share by Revenue ($m), USD Actual 2009-2010 146 Table 100: bioMerieux S.A., Revenue ($m), BRICS Microbiology Culture Market, 2010 148 Table 101: Becton, Dickinson and Company, Revenue ($m), BRICS Microbiology Culture Market, 2010 150 Table 102: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Microbiology Culture Market, 2010 152 Table 103: Thermo Fisher Scientific Inc., Revenue ($m), BRICS Microbiology Culture Market, 2010 154 Table 104: Alere Inc., Revenue ($m), BRICS Microbiology Culture Market, 2010 156 Table 105: Siemens Healthcare, Revenue ($m), BRICS Microbiology Culture Market, 2010 158 Table 106: J.Mitra & Co. Pvt Ltd, Revenue ($m), BRICS Microbiology Culture Market, 2010 159 Table 107: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 167 1.2 List of Figures Figure 1: Microbiology Culture, BRICS, Overall Revenue ($m), 2003-2017 14 Figure 2: Microbiology Culture, BRICS, Overall Revenue ($m), Historic, 2003-2010 16 Figure 3: Microbiology Culture, BRICS, Overall Revenue ($m), Forecast, 2010-2017 18 Figure 4: Microbiology Culture, BRICS, Company share (%), 2010 20 Figure 5: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 22 Figure 6: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24 Figure 7: Microbiology Culture, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26 Figure 8: Bacterial Identification & Susceptibility Testing, Brazil, Revenue ($m), Historic, 2003-2010 28 Figure 9: Bacterial Identification & Susceptibility Testing, Brazil, Revenue ($m), Forecast, 2010-2017 29 Figure 10: Blood Culture, Brazil, Revenue ($m), Historic, 2003-2010 30 Figure 11: Blood Culture, Brazil, Revenue ($m), Forecast, 2010-2017 31 Figure 12: Microbiology Analyzers, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 32 Figure 13: Microbiology Analyzers, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 34 Figure 14: Mycobacteria Culture, Brazil, Revenue ($m), Historic, 2003-2010 36 Figure 15: Mycobacteria Culture, Brazil, Revenue ($m), Forecast, 2010-2017 37 Figure 16: Mycology Culture, Brazil, Revenue ($m), Historic, 2003-2010 38 Figure 17: Mycology Culture, Brazil, Revenue ($m), Forecast, 2010-2017 39 Figure 18: Immunological Culture Identification, Brazil, Revenue ($m), Historic, 2003-2010 40 Figure 19: Immunological Culture Identification, Brazil, Revenue ($m), Forecast, 2010-2017 41 Figure 20: Parasitology Culture, Brazil, Revenue ($m), Historic, 2003-2010 42 Figure 21: Parasitology Culture, Brazil, Revenue ($m), Forecast, 2010-2017 43 Figure 22: Microbiology Culture, Brazil, Company share (%), 2010 45 Figure 23: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 46 Figure 24: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 48 Figure 25: Microbiology Culture, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 50 Figure 26: Bacterial Identification & Susceptibility Testing, Russian Federation, Revenue ($m), Historic, 2003-2010 52 Figure 27: Bacterial Identification & Susceptibility Testing, Russian Federation, Revenue ($m), Forecast, 2010-2017 53 Figure 28: Blood Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 54 Figure 29: Blood Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 55 Figure 30: Microbiology Analyzers, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 56 Figure 31: Microbiology Analyzers, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 58 Figure 32: Immunological Culture Identification, Russian Federation, Revenue ($m), Historic, 2003-2010 60 Figure 33: Immunological Culture Identification, Russian Federation, Revenue ($m), Forecast, 2010-2017 62 Figure 34: Mycobacteria Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 63 Figure 35: Mycobacteria Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 64 Figure 36: Mycology Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 65 Figure 37: Mycology Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 66 Figure 38: Parasitology Culture, Russian Federation, Revenue ($m), Historic, 2003-2010 67 Figure 39: Parasitology Culture, Russian Federation, Revenue ($m), Forecast, 2010-2017 68 Figure 40: Microbiology Culture, Russian Federation, Company share (%), 2010 70 Figure 41: Microbiology Culture, India, Overall Revenue ($m), USD Actual, 2003-2017 72 Figure 42: Microbiology Culture, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 74 Figure 43: Microbiology Culture, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 76 Figure 44: Blood Culture, India, Revenue ($m), Historic, 2003-2010 78 Figure 45: Blood Culture, India, Revenue ($m), Forecast, 2010-2017 79 Figure 46: Mycobacteria Culture, India, Revenue ($m), Historic, 2003-2010 80 Figure 47: Mycobacteria Culture, India, Revenue ($m), Forecast, 2010-2017 81 Figure 48: Bacterial Identification & Susceptibility Testing, India, Revenue ($m), Historic, 2003-2010 82 Figure 49: Bacterial Identification & Susceptibility Testing, India, Revenue ($m), Forecast, 2010-2017 83 Figure 50: Immunological Culture Identification, India, Revenue ($m), Historic, 2003-2010 84 Figure 51: Immunological Culture Identification, India, Revenue ($m), Forecast, 2010-2017 85 Figure 52: Parasitology Culture, India, Revenue ($m), Historic, 2003-2010 86 Figure 53: Parasitology Culture, India, Revenue ($m), Forecast, 2010-2017 87 Figure 54: Microbiology Analyzers, India, Revenue ($m) by Segment, Historic, 2003-2010 88 Figure 55: Microbiology Analyzers, India, Revenue ($m) by Segment, Forecast, 2010-2017 90 Figure 56: Mycology Culture, India, Revenue ($m), Historic, 2003-2010 92 Figure 57: Mycology Culture, India, Revenue ($m), Forecast, 2010-2017 93 Figure 58: Microbiology Culture, India, Company Share (%), 2010 95 Figure 59: Microbiology Culture, China, Overall Revenue ($m), USD Actual, 2003-2017 97 Figure 60: Microbiology Culture, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 99 Figure 61: Microbiology Culture, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 101 Figure 62: Blood Culture, China, Revenue ($m), Historic, 2003-2010 103 Figure 63: Blood Culture, China, Revenue ($m), Forecast, 2010-2017 104 Figure 64: Microbiology Analyzers, China, Revenue ($m) by Segment, Historic, 2003-2010 105 Figure 65: Microbiology Analyzers, China, Revenue ($m) by Segment, Forecast, 2010-2017 107 Figure 66: Mycobacteria Culture, China, Revenue ($m), Historic, 2003-2010 109 Figure 67: Mycobacteria Culture, China, Revenue ($m), Forecast, 2010-2017 110 Figure 68: Bacterial Identification & Susceptibility Testing, China, Revenue ($m), Historic, 2003-2010 111 Figure 69: Bacterial Identification & Susceptibility Testing, China, Revenue ($m), Forecast, 2010-2017 112 Figure 70: Immunological Culture Identification, China, Revenue ($m), Historic, 2003-2010 113 Figure 71: Immunological Culture Identification, China, Revenue ($m), Forecast, 2010-2017 114 Figure 72: Parasitology Culture, China, Revenue ($m), Historic, 2003-2010 115 Figure 73: Parasitology Culture, China, Revenue ($m), Forecast, 2010-2017 116 Figure 74: Mycology Culture, China, Revenue ($m), Historic, 2003-2010 117 Figure 75: Mycology Culture, China, Revenue ($m), Forecast, 2010-2017 118 Figure 76: Microbiology Culture, China, Company share (%), 2010 120 Figure 77: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 122 Figure 78: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 124 Figure 79: Microbiology Culture, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 126 Figure 80: Microbiology Analyzers, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 128 Figure 81: Microbiology Analyzers, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 130 Figure 82: Mycobacteria Culture, South Africa, Revenue ($m), Historic, 2003-2010 132 Figure 83: Mycobacteria Culture, South Africa, Revenue ($m), Forecast, 2010-2017 133 Figure 84: Blood Culture, South Africa, Revenue ($m), Historic, 2003-2010 134 Figure 85: Blood Culture, South Africa, Revenue ($m), Forecast, 2010-2017 135 Figure 86: Bacterial Identification & Susceptibility Testing, South Africa, Revenue ($m), Historic, 2003-2010 136 Figure 87: Bacterial Identification & Susceptibility Testing, South Africa, Revenue ($m), Forecast, 2010-2017 137 Figure 88: Immunological Culture Identification, South Africa, Revenue ($m), Historic, 2003-2010 138 Figure 89: Immunological Culture Identification, South Africa, Revenue ($m), Forecast, 2010-2017 139 Figure 90: Parasitology Culture, South Africa, Revenue ($m), Historic, 2003-2010 140 Figure 91: Parasitology Culture, South Africa, Revenue ($m), Forecast, 2010-2017 141 Figure 92: Mycology Culture, South Africa, Revenue ($m), Historic, 2003-2010 142 Figure 93: Mycology Culture, South Africa, Revenue ($m), Forecast, 2010-2017 143 Figure 94: Microbiology Culture, South Africa, Company share (%), 2010 145 Figure 95: bioMerieux S.A., Company Share (%), BRICS Microbiology Culture Market, 2010 148 Figure 96: Becton, Dickinson and Company, Company Share (%), BRICS Microbiology Culture Market, 2010 150 Figure 97: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Microbiology Culture Market, 2010 152 Figure 98: Thermo Fisher Scientific Inc., Company Share (%), BRICS Microbiology Culture Market, 2010 154 Figure 99: Alere Inc., Company Share (%), BRICS Microbiology Culture Market, 2010 156 Figure 100: Siemens Healthcare, Company Share (%), BRICS Microbiology Culture Market, 2010 158 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
